Clinical Trial Update: Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies [Phase 1]

View source ↗

Summary

Phase I study evaluating intravenous Triapine in combination with pelvic radiation therapy, with or without weekly cisplatin, for locally advanced gynecologic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Ovarian Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Triapine (Triapine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Cervical Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Status: COMPLETED